Glucagon-initiated human growth hormone release: a comparative study

Area of Science:

• Endocrinology
• Hormone research
• Pituitary gland function

Background:

• Human growth hormone (HGH) plays a crucial role in growth and metabolism.
• Assessing anterior pituitary function is vital for diagnosing hormonal disorders.
• Previous methods for HGH stimulation have varying efficacies.

Purpose of the Study:

• To compare the efficacy of glucagon, arginine infusion, tolbutamide, and insulin-induced hypoglycemia in stimulating HGH release.
• To evaluate glucagon as a diagnostic tool for pituitary insufficiency.

Main Methods:

• Twenty healthy adults underwent four HGH stimulation tests: glucagon, arginine infusion, tolbutamide, and insulin hypoglycemia.
• Forty-nine patients with suspected pituitary insufficiency were tested with glucagon, with 25 also receiving arginine infusion.
• HGH levels were measured following each stimulus.

Main Results:

• All four stimuli induced an HGH rise in healthy adults.
• Glucagon elicited the most frequent abnormal HGH response in patients with suspected pituitary insufficiency.
• In some cases, HGH deficiency was the sole detectable anterior pituitary hormone abnormality after glucagon testing.

Conclusions:

• Glucagon is a simple, effective, and potentially superior stimulus for HGH release compared to arginine, tolbutamide, and insulin.
• Glucagon is a valuable and important test for assessing anterior pituitary function and detecting HGH deficiency.